Leukemia cell differentiation: Cellular and molecular interactions of retinoids and vitamin D

General Pharmacology

Volumn 32, Issue 1, 1999, Pages 143-154

  James, Sharon Y ^a   Williams, Marc A ^b   Newland, Adrian C ^b   Colston, Kay W ^a  

^a Division of Gastroenterology   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; ATRA; Differentiation therapy; Nitric oxide; Vitamin D analogs

Indexed keywords

CALCITRIOL; CD23 ANTIGEN; HEMOPOIETIC GROWTH FACTOR; LECTIN; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL 2; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; CELL DIFFERENTIATION; CELL STRAIN HL 60; CLINICAL TRIAL; DRUG POTENTIATION; GENE EXPRESSION REGULATION; HUMAN; LEUKEMIA CELL; MOLECULAR INTERACTION; MONOCYTE; MYELODYSPLASIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR DIFFERENTIATION;

ACUTE DISEASE; APOPTOSIS; CALCITRIOL; CELL DIFFERENTIATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA; NEOPLASM PROTEINS; NITRIC OXIDE; ONCOGENE PROTEINS, FUSION; RETINOIDS; VITAMIN D;

EID: 0032890157     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00098-6     Document Type: Review

References (174)

1. 3. Proc. Natl. Acad. Sci. USA. 78:1981;4990-4995.
2. 3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia. FEBS Lett. 226:1987;58-62.
3. 3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology. 124:1989;2645-2647.
4. Adamson P.C., Boylan J.F., Balis F.M., Murphy R.F., Godwin K.A., Gudas L.J., Poplack D.G. Time course of induction of metabolism of all-trans retinoic acid and the up-regulation of cellular retinoic acid binding protein. Cancer Res. 53:1993;472-476.
5. Amento E.P. Vitamin D and the immune system. Steroids. 49:1987;55-72.
6. Antonson P., Stellan B., Yamanaka R., Xanthopoulos K.G. A novel human CCAAT/enhancer binding protein gene, C/EBPε, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11.2 close to the T-cell receptor α/δ locus. Genomics. 35:1996;30-38.
7. Aubry J., Dugas N., Leconanet-Henchoz S., Ouaaz F., Zhao H., Delfraissy J.F., Graber P., Kolb J.P., Dugas B., Bonnefoy J.Y. The 25 kD soluble CD23 activates type III constitutive nitric oxide synthase activity via CD11b and CD11c expressed by human monocytes. J. Immunol. 159:1997;614-622.
8. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., O'Malley B.W. Cloning and expression of full length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA. 85:1988;3294-3298.
9. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposals for the classification of the acute leukaemias. Br. J. Hematol. 33:1976;451-458.
10. Bettelheim P., Valent P., Andreeff M. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction therapy in de novo acute myeloid leukemia. Blood. 77:1991;700-711.
11. 3 analogues. a novel class of potent regulators of cell growth and immune responses Biochem. Pharmacol. 42:1991;1569-1575.
12. Binderup L. Immunological properties of vitamin D analogues and metabolites. Biochem. Pharmacol. 43:1992;1885-1892.
13. Boise L.H., González-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nuñez G., Thompson C.B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
14. Bouillon R., Garmyn M., Verstuyf A., Segaert S., Casteels K., Mathieu C. Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogues. Eur. J. Endocrinol. 133:1995;7-16. a.
15. Bouillon R., Okamura W.H., Norman A.W. Structure-function relationships in the vitamin D endocrine system. Endo. Rev. 16:1995;200-257. b.
16. Bredt D., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA. 87:1990;682-685.
17. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA. 77:1980;2936-2940.
18. 3 cooperate to promote differentiation of the human promyeloid leukemia cell line HL-60 to monocytes. Leukemia. 8:1994;806-814.
19. Brown T.R.P., Stonehouse T.J., Branch J.S., Brickell P.M., Katz D.R. Stable transfection of U937 cells with sense or antisense RXRα cDNA suggests a role for RXRα in the control of monoblastic differentiation induced by retinoic acid and vitamin D. Exp. Cell Res. 236:1997;94-102.
20. Büchner T., Hiddemann W., Koenigsmann M., Zuhlsdorf M., Wormann B., Boeckmann A., Friere E.A., Innig G., Maschmeyer G., Ludwig W.-D., Sauerland M.-C., Heinecke A., Schulz G. Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. Blood. 78:1991;1190-1197.
21. 3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. Leukemia. 9:1995;410-418.
22. Cannistra S.A., DiCarlo J., Groshek P. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia. Leukemia. 5:1991;230-238.
23. 3. Interplay with retinoid and thyroid hormone signaling. Eur. J. Biochem. 231:1995;517-527.
24. 3 response elements. Norman A.W., Bouillon R., Thomasset M. Vitamin D: Chemistry, Biology and Clinical Application of the Steroid Hormone. 1997;268-275 University of California, Riverside.
25. Carroll Brooks S. III, Sturgill R., Choi J., Yen A. An RXR-selective analogue attenuates the RARα-selective analogue-induced differentiation and non-G1-restricted growth arrest of NB4 cells. Exp. Cell Res. 234:1997;259-269.
26. Castaigne S., Chomienne C., Daniel M.T., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemias. I. Clinical results. Blood. 76:1990;1704-1709.
27. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;941-954.
28. L. Cell Growth Differ. 8:1997;1083-1089.
29. Chen Z., Zue Y., Zhang R., Tao R., Xia X., Li C., Wang W., Zu W., Yao X., Ling B. A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood. 78:1991;1413-1419.
30. Chen Z., Brand N., Chen A., Chen S., Tong J., Wang Z., Waxman S., Zelent A. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor a locus due to a variant t(11;17) translocation in acute promyelocytic leukemia. EMBO J. 12:1993;1161-1167.
31. Chen Z., Guidez F., Rousselot P., Agadir A., Chen S.-J., Wang Z.-Y., Degos L., Zelent A., Waxman S., Chomienne C. PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc. Natl. Acad. Sci. USA. 91:1994;1178-1182.
32. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-457.
33. Chomienne C., Ballerini P., Baltitrand N., Huang M.E., Krawice I., Castaigne S., Fenaux P., Dejean A., Degos L., de Thé H. The retinoic acid receptor alpha gene is rearranged in retinoic acid sensitive promyelocytic leukemia. Leukemia. 4:1990;802-807.
34. Chumakov A.M., Grillier I., Chumakov E., Chih D., Slater J., Koeffler H.P. Cloning of the novel human myeloid-specific C/EBP transcription factor (C/EBPε). Mol. Cell. Biol. 17:1996;1375-1386.
35. Collins S.J., Robertson K.A., Mueller L. Retinoic acid-induced differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RARα). Mol. Cell. Biol. 10:1990;2154-2163.
36. Colston K.W., Chander S.K., Mackay A.G., Coombes R.C. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol. 44:1992;693-702. a.
37. Colston K.W., Mackay A.G., James S.Y., Binderup L., Chander S., Coombes R.C. EB1089. A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro Biochem. Pharmacol. 44:1992;2273-2280. b.
38. Cornic M., Delva L., Castaigne S., Balitrand N., Degos L., Chomienne C. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia. Leukemia. 8:1994;914-917.
39. Cosman D. A family of ligands for the TNF receptor superfamily. Stem Cells. 12:1994;440-455.
40. Cunningham D., Gilchrist N.L., Cowan R.A., Soukup K. Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas. Br. Med. J. 291:1985;1153-1155.
41. Dawson M.I., Elstner E., Kizaki M., Chen D.-L., Pakkala S., Kerner B., Koeffler H.P. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood. 84:1994;446-452.
42. de Thé H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 66:1991;675-684.
43. de Thé H. Altered retinoic acid receptors. FASEB J. 10:1996;955-960.
44. 3 analogues efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines. J. Pharm. Exp. Ther. 271:1994;193-199.
45. Defacque H., Sevilla C., Piquermal D., Rochette-Egly C., Marti J., Commes T. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signalling pathways. Leukemia. 11:1997;221-227.
46. Delia D., Aiello A., Soligo D., Fontanella E., Melani C., Pezzella F., Pierotti M.A., Della Porta G. Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood. 79:1992;1291-1298.
47. Denis M. Tumor necrosis factor and granulocyte-macrophage colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium. killing effector mechanism depends on the generation of reactive oxygen intermediates J. Leukoc. Biol. 49:1991;380-387.
48. 3 analogues on HL-60 myeloid cells. Leuk. Res. 17:1993;749-757.
49. Dubois C., Schlageter M.H., de Gentile A., Guidez F., Balitrand N., Toubert M.E., Krawice I., Fenaux P., Castaigne S., Najean Y., Degos L., Chomienne C. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood. 83:1994;3264-3270. a.
50. Dubois C., Schlageter M.H., de Gentile A., Balitrand N., Toubert M.E., Krawice I., Fenaux P., Castaigne S., Najean Y., Degos L., Chemienne C. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia. 8:1994;1750-1757. b.
51. Dugas B., Mossalayi D.M., Damais C., Kolb J.P. Nitric oxide production by human monocytes/macrophages. Evidence for a role of CD23. Immunol. Today. 16:1995;574-580.
52. Dugas B., Debre P., Moncada S. Nitric oxide is a vital poison inside the immune and inflammatory network. Res. Immunol. 146:1996;664. a.
53. 3 on human promonocytic leukemic cells. Blood. 88:1996;3528-3534. b.
54. Eigler A., Sinha B., Endres S. Nitric oxide releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem. Biophys. Res. Commun. 196:1993;496-501.
55. 3 analogue (KH1060) with 9-cis retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res. 56:1996;3570-3576.
56. 3 analogues and 9-cis retinoic acid. J. Clin. Invest. 99:1997;349-360.
57. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
58. Fogh K., Voorhees J.J., Astrom A. Expression, purification and binding properties of human cellular retinoic acid binding protein type I and type II. Arch. Biochem. Biophys. 300:1993;751-755.
59. Forstermann U., Kleinnert H., Gath I., Schwartz P., Closs E.J., Dunn N.J. Expression and expressional control of nitric oxide synthases in various cell types. Adv. Pharmacol. 34:1995;171-186.
60. Frankel S.R., Eardley A., Lauwers G., Weiss M., Warrell R. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann. Intern. Med. 117:1992;292-296.
61. 3 receptor mediating cell cycle arrest and differentiation. Norman A.W., Bouillon R., Thomasset M. Vitamin D: Chemistry, Biology and Clinical Application of the Steroid Hormone. 1997;188-194 University of California, Riverside.
62. Freemerman A.J., Vrana J.A., Tombes R.M., Jiang H., Chellappan S.P., Fisher P.B., Grant S. Effects of antisense p21 (WAF1/CIP1/MDA6) expression on the induction of differentiation and drug induced apoptosis in human myeloid leukemia cells (HL-60). Leukemia. 11:1997;504-513.
63. Glass C.K. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endo. Rev. 15:1994;391-407.
64. Gottlieb T.M., Oren M. p53 in growth control and neoplasia. Biochim. Biophys. Acta. 1287:1996;77-102.
65. Green S. Promiscuous liaisons. Nature. 361:1993;590-591.
66. Grignani F., Ferrucci P.F., Testa U., Talamo G., Fagioli M., Alcalay M., Mencarelli A., Grignani F., Peschele C., Nicoletti I., Pelicci P.G. The acute promyelocyte leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell. 74:1993;423-431.
67. Grignani F., De Matteis S., Nervi C., Tomassoni L., Gelmetti Cioce M., Fanelli M., Ruthardt M., Ferrara F.F., Zamir I., Seiser C., Grignani F., Lazar M.A., Minucci S., Pelicci P.G. Fusion proteins of the retinoic acid receptor-a recruit histone deacetylase in promyelocytic leukemia. Nature. 391:1998;815-818.
68. Haussler M.R., Jurutka P.W., Hsieh J.-C., Thompson P.D., Haussler C.A., Selznick S.H., Remus L.S., Whitfield G.K. Nuclear vitamin D receptor. structure-function, phosphorylation, and control of gene transcription Feldman D., Glorieux F.H., Pike J.W. Vitamin D. 1997;149-177 Academic Press, San Diego.
69. Hewison M., Barker S., Brennan A., Nathan J., Katz D.R., O'Riordan J.L.H. Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells. Immunology. 68:1989;247-252.
70. Hewison M. Vitamin D and the immune system. J. Endocrinol. 132:1992;173-175.
71. Hewison M., Dabrowski M., Vadher S., Faulkner L., Cockerill F.R., Brickell P.M., O'Riordan J.L., Katz D.R. Antisense inhibition of vitamin D receptor expression induces apoptosis in monoblastoid U937 cells. J. Immunol. 156:1996;4391-4400.
72. Hong S.-H., David G., Wong C.-W., Dejean A., Privalsky M.L. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor a (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA. 94:1997;9028-9033.
73. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc. Natl. Acad. Sci. USA. 80:1983;201-206.
74. Huang M.E., Yu-Chen Y., Shu-Rong C., Lu M.X., Zhoa L., Gu L.J., Wang Z.Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:1988;567-572.
75. James S.Y., Williams M.A., Kelsey S.M., Newland A.C., Colston K.W. The role of vitamin D derivatives and retinoids in the differentiation of human leukemia cells. Biochem. Pharmacol. 54:1997;625-634. a.
76. James S.Y., Turner A., Colston K.W. Induction of apoptosis in human leukemia cells is differentially regulated by vitamin D derivatives and retinoids. Hematology. 2:1997;289-301. b.
77. James S.Y., Williams M.A., Kelsey S.M., Newland A.C., Colston K.W. Interaction of vitamin D derivatives and granulocyte-macrophage colony-stimulating factor in leukemic cell differentiation. Leukemia. 11:1997;1017-1025. c.
78. Jiang H., Lin J., Su Z.Z., Collart F.R., Huberman E., Fisher P.B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
79. Johnson P.R.E., Lin Yu J.A. The role of granulocyte- and granulocyte-macrophage-colony stimulating factors in the treatment of acute myeloid leukemia. Br. J. Hematol. 97:1997;1-8.
80. Jun C.D., Park C.J., Choi B.M., Kwak H.J., Park Y.C., Kim M.S., Park R.K., Chung H.T. Potentiation of the activity of nitric oxide by the protein kinase C activator phorbol ester in human myeloid leukemic HL-60 cells. association with enhanced fragmentation of mature genomic DNA Cell. Immunol. 176:1997;41-49.
81. Kakizuka A., Miller W.H., Umesono K., Warrell R., Frankel S., Dmitrovsky E., Evans R. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor. Cell. 66:1991;663-674.
82. Kantarjian H.M., Estey E.H., Keating M.A. New chemotherapeutive agents in acute myeloid leukemia. Leukemia. 10:1996;S4-S6.
83. Kastner P., Perez A., Lutz Y., Rochette-Egly C., Gaub M.P., Durand B., Lanotte M., Berger R., Chambon P. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL). structural similarities with a new family of oncoproteins EMBO J. 11:1992;629-642.
84. 3 analogues and other differentiation inducers in combination with antileukemic drugs. in vitro and in vivo studies Cancer Res. 47:1987;567-572.
85. 3-induced monocytoid differentiation in the U937 human leukemic cell line. Leuk. Res. 14:1990;1027-1033.
86. Kelsey S.M., Newland A.C., Cunningham J., Makin H.L.J., Coldwell R.D., Mills M.J., Grant I.R. Sustained hematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes. Lancet. 340:1992;316-317. a.
87. 3 and GM-CSF. Leuk. Res. 16:1992;427-434. b.
88. 3. Leuk. Res. 15:1991;409-418.
89. 3 receptor RNA. expression in hematopoietic cells Blood. 77:1991;1238-1247.
90. Kliewer S.A., Umesono K., Mangelsdorf D.J., Evans R.M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D signalling. Nature. 355:1992;446-449.
91. 3 in vitro and in vivo effects on human preleukemic and leukemic cells. Cancer Treat. Res. 69:1985;1399-1407.
92. 3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood. 82:1993;1300-1307.
93. 3 recepotors in human promyelocytic leukemia cells (HL-60) during homologous regulation. J.Biol. Chem. 264:1989;13701-13705.
94. 3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts. Leukemia. 10:1996;1751-1757.
95. Levin A.A., Sturzenbecker L.J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeison C., Rosenberger M., Lovey A., Grippo J.F. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRa. Nature. 355:1992;359-361.
96. Liew F.Y., Cox F.E.G. Nonspecific defence mechanism. the role of nitric oxide Immunol. Today. 12:1991;17-21.
97. 3 leads to the differentiation of the myelomonocytic cell line U937. Genes Dev. 10:1996;142-153. a.
98. Liu M., Iavarone A., Freedman L.P. Transcriptional activation of the human p21 (WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271:1996;31723-31728. b.
99. Lowenberg B., Touw I.P. Hematopoietic growth factors and their receptors in acute leukemia. Blood. 81:1993;281-292.
100. 3-activated expression of the rat osteocalcin gene. Mol. Cell. Biol. 13:1993;5907-5917.
101. Maciejewski J.P., Selleri C., Sato T., Cho H.J., Keefer L.K., Nathan C.F., Young N.S. Nitric oxide suppression of human hemopoiesis in vitro. contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha J. Clin. Invest. 96:1995;1085-1092.
102. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:1997;323-350.
103. Magrinat G., Mason S.N., Shami P.J., Weinberg J.B. Nitric oxide modulation of leukemia cell differentiation and gene expression. Blood. 80:1992;1880-1884.
104. Mangelsdorf D.J., Umesono K., Evans R.M. The retinoid receptors. Sporn M.B., Roberts A.B., Goodman D.S. The retinoids. biology, chemistry and medicine:1994;319-349 Raven Press Ltd, New York.
105. 3 and the immune system. Mol. Cell. Endocrinol. 43:1985;113-122.
106. Marsden P.A., Schappert K.T., Chen H.S., Flowers M., Sundell C.L., Wilcox J.N., Lamas S., Michel T. Molecular cloning and characterisation of human endothelial nitric oxide synthase. FEBS Lett. 307:1992;287-293.
107. 3/retinoid acid induction of human promyelocytic cell lines. enhanced phagocytic cell maturation and hybrid granulomonocytic phenotype Cell Growth Differ. 6:1995;493-503.
108. 3 inhibits proliferation of human promyelocytic leukemia (HL-60) cells and induces monocyte-macrophage differentiation in HL-60 and normal bone marrow cells. Leuk. Res. 7:1983;51-55.
109. McTernan P.G., Sheppard M.C., Williams G.R. Hormone-induced changes in nuclear receptor stoichiometry in HL-60 cells correlate with induction of monocyte or neutrophil differentiation. J. Endocrinol. 156:1998;135-148.
110. Mehta A.B., Kumaran T.O., Marsh G.W., McCarthy D.M. Treatment of advanced myelodysplastic syndrome with alfacalcidol. Lancet. 2:1984;761.
111. Mehta K., McQueen T., Neamati N., Collins S., Andreeff M. Activation of retinoid receptors RARα and RXRα induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Differ. 7:1996;179-186.
112. Mellibovsky L., Díez A., Pérez-Vila E., Serrano S., Nacher M., Aubía J., Supervía A. Vitamin D treatment in myelodysplastic syndromes. Br. J. Hematol. 100:1998;516-520.
113. Messmer U.K., Reimer D.M., Reed D.M., Brune B. Nitric oxide induced poly(ADP-ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by bcl-2. FEBS Lett. 384:1996;162-166.
114. Miller W.H., Levine K., DeBlasio A., Frankel S.R., Dmitrovsky E., Warrell R.P. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcripton polymerase chain reaction assay for PML-RARα fusion mRNA. Blood. 82:1993;1689-1694.
115. Miller W.H., Jakubowski A., Tong W.A., Miller V.A., Rigas J.R., Bendetti F., Gill G.M., Truglia J.A., Ulm E., Shirley M., Warrell R.P. 9-cis retinoic acid induces complete remission, but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood. 85:1995;3021-3027.
116. Miyauchi J., Kelleher C.A., Yang Y.C., Wong G.G., Clark S.C., Minden M.D., Minkin S., McCulloch E.A. The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood. 70:1987;657-663.
117. Mørk Hansen C., Mäenpää P.H. EB1089, a novel vitamin D analogue with strong antiproliferative and differentiation-inducing effects on target cells. Biochem. Pharmacol. 54:1997;1173-1179.
118. Morosetti R., Park D.J., Chumakov A.M., Grillier I., Shiohara M., Gombart A.F., Nakamaki T., Weinberg K., Koeffler H.P. A novel, myeloid transcription factor, C/EBPε, is upregulated during granulocytic, but not monocytic, differentiation. Blood. 90:1997;2591-2600.
119. 3 for prolongation of leukemic transformation-free survival in myelodysplastic syndromes. Am. J. Hematol. 38:1991;67-68.
120. Nagy L., Thomázy V.A., Shipley G.L., Fésüs L., Lamph W., Heyman R.A., Chandraratna R.A.S., Davies P.J.A. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15:1995;3540-3551.
121. Nakane M., Schmidt H.H.H.W., Pollock J.S., Forstermann U., Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett. 316:1993;175-180.
122. Naoe T., Yoshida H., Kitamura K., Chino M., Osumi K., Ohno R. Delayed and insufficient restoration of PML and PML-RARα subcellular localization after exposure in vitro to retinoic acids in all-trans retinoic acid resistant APL cells. Leukemia. 9:1995;1610-1611.
123. Naumovski L., Cleary M.L. Bcl-2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood. 83:1994;2261-2267.
124. Nguyen H.Q., Hoffman-Liebermann B., Liebermann D.A. The zinc finger transcription factor Egr-1 is essential for and resticts differentiation along the macrophage lineage. Cell. 72:1993;197-209.
125. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerises in vivo with a conserved homologue, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
126. Oster W., Cicco N.A., Klein H., Hirano T., Kishimot T., Lindemann A., Mertelesmann R.H., Herrmann F. Participation of the cytokines interleukin-6, tumor necrosis factor-alpha, and interleukin-1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J. Clin. Invest. 84:1989;451-457.
127. Ostrem V.K., Lau W.F., Lee S.H., Perlman K., Prahl J., Schnoes H.K., DeLuca H.F. Induction of monocytic differentiation of HL-60 cells by 1,25-dihydroxyvitamin D analogues. J. Biol. Chem. 262:1987;4164-4171.
128. Ouaaz F., Sola B., Issaly F., Kolb J.P., Davi F., Mentz F., Arock M., Paul-Eugene N., Korner M., Dugas B., Debre P., Mossalayi M.D. Growth arrest and terminal differentiation of leukemic myelomonocytic cells induced through ligation of the CD23 surface antigen. Blood. 84:1994;3095-3104.
129. 3 analogues. effects on leukemic clonal growth and differentiation, and on serum calcium levels Leuk. Res. 19:1995;65-72.
130. Pakkala I., Savli H., Knuutila S., Binderup L., Pakkala S. CB1093, a novel vitamin D analogue; effects on differentiation and clonal growth on HL-60 and de novo leukemia cells. Leuk. Res. 21:1997;321-326.
131. Park J.R., Robertson K., Hickstein D.D., Tsai S., Hockenbery D.M., Collins S.J. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood. 84:1994;440-445.
132. 3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1b production. J. Clin. Invest. 100:1997;1716-1724.
133. Pollock J.S., Forstermann U., Mitchell J.A., Warner T.D., Schmidt H.H.W., Nakane M., Murad F. Purification and characterisation of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;10480-10484.
134. 3 in nude mice bearing transplantable human myelogenous leukemic cell lines. Exp. Hematol. 13:1985;722-732.
135. Redner R.L., Rush E.A., Faas S., Rudert W.A., Cory S.J. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood. 87:1996;882-886.
136. Redner R.L., Corey S.J., Rush E.A. Differentiation of t(5;17) variant acute promyelocytic leukemic blasts by all-trans retinoic acid. Leukemia. 11:1997;1014-1016.
137. 3. Am. J. Hematol. 23:1986;175-178.
138. Rigas J.R., Francis P.A., Muindi J.R.F., Kris M.G., Huselton C., DeGrazia F., Orazem J.P., Young C.W., Warrell R.P. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans retinoic acid and its modulation by ketoconazole. J. Natl. Cancer Inst. 85:1993;1921-1926.
139. Rodeberg D.A., Chaet M.S., Bass R.C., Arkovitz M.S., Garcia V.S. Nitric oxide. an overview Am. J. Surg. 170:1995;292-303.
140. Roman V., Dugas N., Abadie A., Amirand C., Zhao H., Dugas B., Kolb J.P. Characterisation of a constitutive type II nitric oxide synthase in human U937 monocytic cells. stimulation by soluble CD23 Immunology. 91:1997;643-648.
141. Rowe J., Liesveld J.L. Hematopoietic growth factors in acute leukemia. Leukemia. 11:1997;328-341.
142. Sachs L. Control of normal differentiation and the phenotypic reversion of malignancy in myeloid leukemia cells. Nature. 274:1987;535-538.
143. Sanz C., Benito A., Silva M., Albella B., Richard C., Segovia J.C., Insunza A., Bueren J.A., Fernández-Luna J.L. The expression of bcl-x is down-regulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage. Blood. 89:1997;3199-3204.
144. Schräder M., Bendik I., Becker-André M., Carlberg C. Interaction between retinoic acid and vitamin D signalling pathways. J. Biol. Chem. 268:1993;17830-17836.
145. 3 response elements formed by inverted palindromes. polarity-directed ligand sensitivity of VDR-RXR heterodimer-mediated transactivation Mol. Cell. Biol. 15:1995;1154-1161.
146. Shami P.J., Moore J.O., Gockerman J.P., Hathorn J.W., Misukonis M.A., Weinberg J.B. Nitric oxide modulation of the growth and differentiation of freshly isolated acute nonlymphocytic leukemia cells. Leuk. Res. 19:1995;527-533.
147. + human bone marrow cells. Blood. 87:1996;977-982.
148. Sporn M.B., Roberts A.B., Goodman D.S. The retinoids. biology, chemistry and medicine:1994;Raven Press, New York.
149. Steinman R.A., Hoffman B., Iro A., Guillouf C., Liebermann D.A.,
150. 3 on the differentiation of the human monocytic cell line U937. Leuk. Res. 15:1991;1145-1152.
151. Takeshita A., Shibata Y., Shinjo K., Yanagi M., Tobita T., Ohnishi K., Miyawaki S., Shudo K., Ohno R. Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am80. Ann. Intern. Med. 124:1996;893-896.
152. Tenen D.G., Hromas R., Licht J.D., Zhang D.-E. Transcription factors, normal myeloid development, and leukemia. Blood. 90:1997;489-519.
153. 3 Cancer Res. 54:1994;4508-4515.
154. Thornberry N.A. The caspase family of cysteine proteases. Br. Med. Bull. 53:1997;478-490.
155. 3 receptors. Cell. 65:1991;1255-1266.
156. Vellenga E., Young D.C., Wagner K., Wiper P., Ostapovicz D., Griffen J.D. The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood. 69:1987;1771-1776.
157. 2 and their combinations. J. Steroid Biochem. Mol. Biol. 60:1997;87-97.
158. 3 and retinoic acid (all trans or 9-cis). J. Steroid Biochem. Mol. Biol. 53:1995;431-441.
159. Visani G., Tosi P., Ottaviani E., Zaccaria A., Baccini C., Manfroi S., Pastano R., Remiddi C., Morelli A., Molinari A.L., Zanchini R., Tura S. All-trans retinoic acid and in vitro cytokine production by acute promyelocytic leukemia cells. Eur. J. Hematol. 57:1996;301-306.
160. Wang S., Liang Y., Wesley R.A., Danner R.L. Nitric oxide increases tumor necrosis factor production in differentiated U937 cells by decreasing cyclic AMP. J. Biol. Chem. 272:1997;5959-5965.
161. Warrell R.P., Frankel S.R., Miller W.H., Sheinberg D.A., Itri L.M., Hittelman W.N., Vyas R., Andreef M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M.S., Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 324:1991;1385-1393.
162. Williams M.A., Newland A.C., Kelsey S.M. Monocyte-mediated killing of human leukemia is enhanced by administration of granulocyte-macrophage colony stimulating factor following chemotherapy. Br. J. Hematol. 98:1997;960-968.
163. Williams M.A., White S.A., Miller J.J., Toner C., Withington S., Newland A.C., Kelsey S.M. Granulocyte-macrophage colony-stimulating factor induces activation and restores respiratory burst activity in monocytes from septic patients. J. Infect. Dis. 177:1998;107-115.
164. Wu Y.L., Jiang X.R., Allen P.D., Jia L., Dronfield D.M., Newland A.C., Kelsey S.M. Modulation of surface TNF expression by human leukemic cells alters their sensitivity to exogenous TNF. Leuk. Res. 20:1996;47-55.
165. 3 protects human leukemic cells from tumor necrosis factor-induced apoptosis via inactivation of cytosolic phospholipase A2. Cancer Res. 58:1998;633-640.
166. 3 protects HL-60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp. Cell Res. 209:1993;367-374.
167. Yan L., Wang S., Rafferty S.P., Wesley R.A., Danner R.L. Endogenously produced nitric oxide increases tumor necrosis factor-a production in transfected human U937 cells. Blood. 90:1997;1160-1167.
168. Yang E., Korsmeyer S.J. Molecular thanatopsis. a discourse on the bcl-2 family and cell death Blood. 88:1996;386-401.
169. Yoshida H., Kitamura K., Tanaka K., Omura S., Miyazaki T., Hachiya T., Ohno R., Naoe T. Accelerated degradation of PML-retinoic acid receptor α (RARα) oncoprotein by all-trans retinoic acid in acute promyelocytic leukemia. possible role of the proteasome pathway Cancer Res. 56:1996;2945-2948.
170. Zhong W.W., Burke P.A., Drotar M.A., Chavali S.R., Frose R.A. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology. 84:1995;446-452.
171. 3 prolongs survival time of leukemic mice. Proc. Natl. Acad. Sci. USA. 87:1990;3929-3932.
172. 3 analogue with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood. 78:1991;75-82.
173. 3 and granulocyte-macrophage colony stimulating factor. J. Leukoc. Biol. 44:1988;187-191.
174. 3 on the differentiation of the human monocytic cell line U937. Blood. 71:1988;619-624.